You just read:

Hollister Biosciences Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA

News provided by

Hollister Biosciences Inc.

Feb 25, 2020, 03:01 ET